Tissue Diagnostics Market Trends 2014 To 2020 by Grand View Research, Inc.

Tissue

Diagnostics

Market

Analysis

By

Product

(Consumables, Instruments), By Disease (Breast Cancer, Prostrate Cancer, lymphoma, Non-Small Cell Lung Carcinoma

(NSCLC),

Gastric

Cancer),

Technology

(Immunohistochemistry, Digital Pathology and Workflow Management, In-Situ-Hybridization, Special Staining), By End

User

(Pharmaceutical

Companies,

Hospitals,

Contract Research Organizations, Research Laboratories) And Segment Forecasts To 2020

Tissue diagnostic techniques consist of a set of methods used for primary diagnosis of stages, monitoring, prognosis and managing diseases, especially cancer such as breast cancer, prostate cancer and gastric cancer.

Growing prevalence of cancer, rising use and adoption of tissue diagnostic techniques in personalized medicine are some key factors expected to drive market growth during the forecast period. Some other drivers of this market include growing demand for accurate diagnostic technologies, rising demand for cost-effective and safer treatments and increasing global geriatric population base.

For More Information on "Tissue Diagnostics Market Research Reports" visit

-

http://www.grandviewresearch.com/industry-analysis/tissue-

diagnostics-market

Key product segments of the tissue diagnostics market include consumables and instruments. Instruments are expected to dominate the overall market throughout the forecast period.

High prices and growing market penetration rates associated with these products are some factors expected to drive segment growth. R&D investments made in compliance with the need for device automation and work flow integration are also expected to drive the tissue diagnostics instruments market. Technology segments of this market include immunohistochemistry (IHC), digital pathology and workflow management, in-situ-hybridization (ISH) and special staining.

North America is identified as the largest regional market. Presence of sophisticated healthcare infrastructure and reimbursement framework in the region are some key factors accounting for its market position. In addition, high market penetration of advanced diagnostic techniques is expected to boost growth over the next six years. Key players of this market include Abbott Laboratories, Agilent Technologies, BioGenex Laboratories, Bio SB, Danaher Corporation, Cell Signaling Technology, Advanced Cell Diagnostics (ACD), Life Technologies, Roche Diagnostics, Novartis and Thermo Fisher Scientific.

Request TOC of “Tissue Diagnostics Market Research Reports" visit http://www.grandviewresearch.com/industry-analysis/tissue-diagnosticsmarket/request-toc About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact: Sherry James Corporate Sales Specialist, U.S.A. Grand View Research, Inc. United States Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: sales@grandviewresearch.com Website: Grand View Research Blog Site: http://marketshare.blog.com/